BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nocentini A, Supuran CT, Winum JY. Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018). Expert Opin Ther Pat. 2018;28:493-504. [PMID: 29727210 DOI: 10.1080/13543776.2018.1473379] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 15.7] [Reference Citation Analysis]
Number Citing Articles
1 Silva MP, Saraiva L, Pinto M, Sousa ME. Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications. Molecules 2020;25:E4323. [PMID: 32967170 DOI: 10.3390/molecules25184323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
2 Soydan E, Olcay AC, Bilir G, Taş Ö, Şentürk M, Ekinci D, Supuran CT. Investigation of pesticides on honey bee carbonic anhydrase inhibition. J Enzyme Inhib Med Chem 2020;35:1923-7. [PMID: 33078633 DOI: 10.1080/14756366.2020.1835885] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Yan Y, Li Z, Ning X, Deng J, Yu J, Luo Y, Wang Z, Li G, Li G, Xiao Y. Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases. Bioorganic & Medicinal Chemistry Letters 2021;41:127956. [DOI: 10.1016/j.bmcl.2021.127956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Coghi PS, Zhu Y, Xie H, Hosmane NS, Zhang Y. Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents. Molecules 2021;26:3309. [PMID: 34072937 DOI: 10.3390/molecules26113309] [Reference Citation Analysis]
5 Xiao YC, Chen XP, Deng J, Yan YH, Zhu KR, Li G, Yu JL, Brem J, Chen F, Schofield CJ, Li GB. Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistance. Chem Commun (Camb) 2021;57:7709-12. [PMID: 34259249 DOI: 10.1039/d1cc03026d] [Reference Citation Analysis]
6 Bonardi A, Nocentini A, Cadoni R, Del Prete S, Dumy P, Capasso C, Gratteri P, Supuran CT, Winum JY. Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium Vibrio cholerae. ACS Med Chem Lett 2020;11:2277-84. [PMID: 33214840 DOI: 10.1021/acsmedchemlett.0c00403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Veggiani G, Gerpe MCR, Sidhu SS, Zhang W. Emerging drug development technologies targeting ubiquitination for cancer therapeutics. Pharmacol Ther 2019;199:139-54. [PMID: 30851297 DOI: 10.1016/j.pharmthera.2019.03.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
8 Niemczyk E, Pogrzeba J, Adamczyk-Woźniak A, Lipok J. Boronic Acids of Pharmaceutical Importance Affect the Growth and Photosynthetic Apparatus of Cyanobacteria in a Dose-Dependent Manner. Toxins (Basel) 2020;12:E793. [PMID: 33322165 DOI: 10.3390/toxins12120793] [Reference Citation Analysis]
9 Adamczyk-woźniak A, Sporzyński A. The influence of ortho-substituents on the properties of phenylboronic acids. Journal of Organometallic Chemistry 2020;913:121202. [DOI: 10.1016/j.jorganchem.2020.121202] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
10 Oguz M, Kalay E, Akocak S, Nocentini A, Lolak N, Boga M, Yilmaz M, Supuran CT. Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action. J Enzyme Inhib Med Chem 2020;35:1215-23. [PMID: 32401067 DOI: 10.1080/14756366.2020.1765166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
11 Giordani F, Paape D, Vincent IM, Pountain AW, Fernández-Cortés F, Rico E, Zhang N, Morrison LJ, Freund Y, Witty MJ, Peter R, Edwards DY, Wilkes JM, van der Hooft JJJ, Regnault C, Read KD, Horn D, Field MC, Barrett MP. Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs. PLoS Pathog 2020;16:e1008932. [PMID: 33141865 DOI: 10.1371/journal.ppat.1008932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Reguera RM, Pérez-pertejo Y, Gutiérrez-corbo C, Domínguez-asenjo B, Ordóñez C, García-estrada C, Martínez-valladares M, Balaña-fouce R. Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 2019;91:1385-404. [DOI: 10.1515/pac-2018-1102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Dickie EA, Giordani F, Gould MK, Mäser P, Burri C, Mottram JC, Rao SPS, Barrett MP. New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story. Trop Med Infect Dis 2020;5:E29. [PMID: 32092897 DOI: 10.3390/tropicalmed5010029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
14 Liu RJ, Long T, Li H, Zhao J, Li J, Wang M, Palencia A, Lin J, Cusack S, Wang ED. Molecular basis of the multifaceted functions of human leucyl-tRNA synthetase in protein synthesis and beyond. Nucleic Acids Res 2020;48:4946-59. [PMID: 32232361 DOI: 10.1093/nar/gkaa189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Nocentini A, Hewitt CS, Mastrolorenzo MD, Flaherty DP, Supuran CT. Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2021;36:1061-6. [PMID: 34030562 DOI: 10.1080/14756366.2021.1929202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Kim SH, Liu C, Zhou Y, Zhang Y, Mcgregor C, Steere L, Frederick BH, Liu CT, Whitesell L, Cowen LE. Inhibiting Protein Prenylation with Benzoxaboroles to Target Fungal Plant Pathogens. ACS Chem Biol 2020;15:1930-41. [DOI: 10.1021/acschembio.0c00290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
17 Larcher A, Nocentini A, Supuran CT, Winum JY, van der Lee A, Vasseur JJ, Laurencin D, Smietana M. Bis-benzoxaboroles: Design, Synthesis, and Biological Evaluation as Carbonic Anhydrase Inhibitors. ACS Med Chem Lett 2019;10:1205-10. [PMID: 31413806 DOI: 10.1021/acsmedchemlett.9b00252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Romero-Aguilar KS, Arciniega-Martínez IM, Farfán-García ED, Campos-Rodríguez R, Reséndiz-Albor AA, Soriano-Ursúa MA. Effects of boron-containing compounds on immune responses: review and patenting trends. Expert Opin Ther Pat 2019;29:339-51. [PMID: 31064237 DOI: 10.1080/13543776.2019.1612368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 Angeli A, Carta F, Nocentini A, Winum JY, Zalubovskis R, Akdemir A, Onnis V, Eldehna WM, Capasso C, Simone G, Monti SM, Carradori S, Donald WA, Dedhar S, Supuran CT. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites 2020;10:E412. [PMID: 33066524 DOI: 10.3390/metabo10100412] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 28.0] [Reference Citation Analysis]
20 Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561-80. [PMID: 33615947 DOI: 10.1080/14756366.2021.1882453] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
21 Walker AL, Denis A, Bingham RP, Bouillot A, Edgar EV, Ferrie A, Holmes DS, Laroze A, Liddle J, Fouchet M, Moquette A, Nassau P, Pearce AC, Polyakova O, Smith KJ, Thomas P, Thorpe JH, Trottet L, Wang Y, Hovnanian A. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Bioorganic & Medicinal Chemistry Letters 2019;29:126675. [DOI: 10.1016/j.bmcl.2019.126675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
22 Tevyashova AN, Korolev AM, Mirchink EP, Isakova EB, Osterman IA. Synthesis and evaluation of biological activity of benzoxaborole derivatives of azithromycin. J Antibiot 2019;72:22-33. [DOI: 10.1038/s41429-018-0107-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
23 Zhang J, Zhang J, Hao G, Xin W, Yang F, Zhu M, Zhou H. Design, Synthesis, and Structure–Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents. J Med Chem 2019;62:6765-84. [DOI: 10.1021/acs.jmedchem.9b00736] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
24 Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opinion on Drug Discovery 2019;14:1175-97. [DOI: 10.1080/17460441.2019.1651289] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 25.0] [Reference Citation Analysis]
25 Diaz A, Guttman-Yassky E. Topical agents for the treatment of atopic dermatitis. Expert Rev Clin Immunol 2019;15:369-82. [PMID: 30587053 DOI: 10.1080/1744666X.2019.1564038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
26 Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15:671-86. [PMID: 32208982 DOI: 10.1080/17460441.2020.1743676] [Cited by in Crossref: 25] [Cited by in F6Publishing: 36] [Article Influence: 25.0] [Reference Citation Analysis]
27 Li X, Wu S, Dong G, Chen S, Ma Z, Liu D, Sheng C. Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer. ACS Med Chem Lett 2020;11:439-44. [PMID: 32292547 DOI: 10.1021/acsmedchemlett.9b00513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
28 Swain B, Angeli A, Angapelly S, Thacker PS, Singh P, Supuran CT, Arifuddin M. Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors. J Enzyme Inhib Med Chem 2019;34:1199-209. [PMID: 31237458 DOI: 10.1080/14756366.2019.1629432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
29 Lunde CS, Stebbins EE, Jumani RS, Hasan MM, Miller P, Barlow J, Freund YR, Berry P, Stefanakis R, Gut J, Rosenthal PJ, Love MS, McNamara CW, Easom E, Plattner JJ, Jacobs RT, Huston CD. Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nat Commun 2019;10:2816. [PMID: 31249291 DOI: 10.1038/s41467-019-10687-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
30 Langella E, Alterio V, D'Ambrosio K, Cadoni R, Winum JY, Supuran CT, Monti SM, De Simone G, Di Fiore A. Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity. J Enzyme Inhib Med Chem 2019;34:1498-505. [PMID: 31423863 DOI: 10.1080/14756366.2019.1653291] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Küçükbay H, Gönül Z, Küçükbay FZ, Angeli A, Bartolucci G, Supuran CT. Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety. J Enzyme Inhib Med Chem 2020;35:1021-6. [PMID: 32297533 DOI: 10.1080/14756366.2020.1751620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Chong PY, Shotwell JB, Miller J, Price DJ, Maynard A, Voitenleitner C, Mathis A, Williams S, Pouliot JJ, Creech K, Wang F, Fang J, Zhang H, Tai VW, Turner E, Kahler KM, Crosby R, Peat AJ. Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. J Med Chem 2019;62:3254-67. [PMID: 30763090 DOI: 10.1021/acs.jmedchem.8b01719] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
33 Fernandes GFS, Denny WA, Dos Santos JL. Boron in drug design: Recent advances in the development of new therapeutic agents. Eur J Med Chem 2019;179:791-804. [PMID: 31288128 DOI: 10.1016/j.ejmech.2019.06.092] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 24.0] [Reference Citation Analysis]